Fact CheckerSign in

NCT07309718Recruiting

MPR for Stroke Risk Assessment of ICAS

MRI-Derived Pressure Ratio: a Novel Noninvasive Hemodynamic Biomarker for Stroke Risk Stratification in Intracranial Atherosclerotic Stenosis

Source: ClinicalTrials.gov · Last updated 30 Dec 2025

Brief summary (registry, in English)

Intracranial atherosclerotic stenosis (ICAS) carries substantial stroke risk despite optimal medical treatment. Current risk stratification relies primarily on stenosis severity, but novel hemodynamic markers may improve prediction. In this multiple prospective registry study we aim to investigate whether regional hemodynamics, measured by a novel Magnetic resonance imaging-derived Pressure Ratio (MPR) technique, are associated with stroke risk in ICAS.

Status (registry)
Recruiting
Study type
Observational
Enrollment
400 (estimated)
First submitted
15 Dec 2025
Start date
Dec 2025
Primary completion date
Dec 2027
Lead sponsor
Xuanwu Hospital, Beijing
Diseases
Stroke
NCT number
NCT07309718

What you commit to

  • Study type: Observational
  • Planned participants: 400
  • From Dec 2025 to the primary completion date, Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Contraindications to antiplatelet therapy or statins.
  • Inability to undergo MRI due to metal implants or claustrophobia.

Other illness

  • Non-atherosclerotic intracranial lesions, including moyamoya disease, vasculitis, vascular dissection, autoimmune diseases, or congenital/genetic abnormalities.

Other

  • More than 50% stenosis of the extracranial carotid artery on the ipsilateral side.
  • Large cerebral infarction involving more than one-half of the territory on DWI imaging, or a baseline modified Rankin Scale score ≥3.

Who the study is looking for

  • Adults aged 18 to 80 years.
  • Intracranial atherosclerotic stenosis ICAS involving a culprit artery in the anterior circulation.
  • Intracranial arterial stenosis of 50% to 99% as measured by the WASID method using TCD, CTA, MRA, or DSA.
  • Written informed consent obtained from the participant or a legal representative.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Neurosurgery, Xuanwu hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.